. A diagnosis of OSAS was retained if the AHI was 15 or more. For patients treated by N-CPAP, the pressure was adjusted during a full night PSG after two to four nights of habituation to the device. 17 This was not possible for one patient only (patient 16). A predetermined pressure was then chosen arbitrarily and a nocturnal oximetry was performed that confirmed the efficacy of that level of N-CPAP in abolishing SaO2 falls.
The N-CPAP was administered using commercially available machines delivering air. Patients underwent various surgical procedures as described in Table 4 . They were operated on by different surgeons according to their usual practice. Anesthesia was conducted by various anesthetists using the habitual technique for each particular procedure, taking into account the as- IND=not done. sociated diseases of the patient (Tables 4 and 5 ). For instance, patients undergoing coronary artery bypass graft (CABG) surgery received, as usual in our institution, high-dose opioid anesthesia. The only difference from routine practice was the avoidance of sedative premedication for some patients in whom tracheal intubation was expected to be difficult (patients 5, 6, 7, and 15) (Table 5). Except for two patients submitted to nasal surgery and unable to tolerate N-CPAP while asleep (patients 5 and 6), the postoperative pain and anxiety management did not differ from the usual practice, including the use of patient-controlled opioid infusion in three patients (patients 9, 10, and 12).
Following the initial experience with the two first patients of our series (patients 1 and 2, see further), all patients with OSAS were started on a regimen of N-CPAP before surgery and were put back on N-CPAP as soon as extubated. The N-CPAP was maintained nearly continuously for the first 24 to 48 hours, ie, until the need for sedation and opioid analgesia had disappeared. Thereafter, N-CPAP was used only during sleep, at night, and during daytime naps. Postoperative continuous recording of SaO2 could be obtained in six patients, including two receiving treatment with opioids using a patient-controlled analgesia device. Recordings were performed at least during their first night on the ward, which corresponded to the first to sixth postoperative nights. According to the judgment of the responsible physician, some patients received supplemental oxygen (0.5 to 8 L/min) administered through a port in the nasal mask of the N-CPAP system. Oxygen was administered in the intensive care unit (ICU) (patients 3, 4, 8, 10, 12, 13, 14 , and 16) and on the ward (patients 10 and 14), for a low (<90%) baseline SaO2, irrespective of cyclic falls in SaO2 . RESULTS We shall first report briefly on the cases of three representative patients and then give the general results. Patient 
1
This 62-year-old man was scheduled for CABG surgery. OSAS had been diagnosed at another hospital several weeks before surgery. A treatment with N-CPAP had been proposed but not instituted because it was deemed that his coronary artery disease problem had priority. Myocardial revascularization was performed using one venous and two arterial grafts. The procedure lasted 8 h. Postoperative evolution was complicated by bleeding and cardiovas- This 55-year-old man was scheduled for CABG surgery because of worsening angina for the last 4 months. OSAS was suspected at a preoperative medical examination for autologous blood predeposit and was confirmed by PSG. He was started on a regimen of N-CPAP 3 weeks before the operation. Myocardial revascularization was performed using one arterial and two saphenous grafts. It was a 5-h procedure. The patient, extubated the next morning, was put on a regimen of nearly continuously N-CPAP for 48 h and then for every night and naps. The only problems he experienced were hypertension (treated by dihydralazine) and transient oliguria responding to furosemide therapy. He left the ICU on POD 3 and the hospital on the ninth POD.
GENERAL RESULTS
As shown in Tables 1 and 2, our patients 15 ,ug.kgwas fragmented (median MAI=43) and minimal oxygen saturation ranged from 20 to 87% (median minimal SaO2=71%). Treatment with N-CPAP corrected both SaO2 falls due to apneas and hypopneas (median minimal SaO2=87.5%) and sleep fragmentation (median MAI=9) ( Table 1 ). Only two patients had never smoked and five were still smoking the week before surgery. Nevertheless, daytime blood gas values were within normal range or only slightly altered and pulmonary function test results were rarely worrisome. All our patients presented, besides OSAS, one or several coexisting medical problems usually considered as risk factors for anesthesia and surgery18 (Table 3) .
Surgical procedures ranged from minor otorhinolaryngologic (ear, nose, and throat) procedures to CABG using internal mammary grafts (Table 4) .
Eleven patients received opioids postoperatively, and three used a patient-controlled analgesia device (Table 5) infusing morphine (2 patients) or piritramide (an opioid). In the two patients (patients 9 and 12) with continuous SaO2 recording during patientcontrolled analgesia, only small falls in SaO2 were noted (Fig 1) . It less important during 02 administration).
The median ICU and postoperative hospital stay lengths were the usual ones for each type of surgery in our institution (Table 4) . Patients 5 and 6 were admitted to the ICU for immediate postoperative monitoring rather than for therapeutic reasons.
Apart from patients 1, 2, and 3 described in detail previously, complications were as follows: three patients developed transient pulmonary infiltrates successfully treated with antibiotics, one patient had a cardiogenic pulmonary edema (rapidly resolved with diuretics) and a phrenic palsy, and one patient had excessive bronchial secretions necessitating intensive chest physiotherapy (Table 4) . DISCUSSION The main result of this survey is that patients with that the above recommendations are well founded and reasonable. By contrast, our patients were treated in a conventional way, with doses of opioids and sedatives usually given for their type of surgery in our institution. In particular, high doses of opioids were used for anesthesia in cardiac surgery, which were 10 to 100 times higher than those reported or recommended in the above-mentioned studies.19 No restriction was applied to the use of analgesia, including patient-controlled analgesia with opioids. The rationale for this attitude was that patients were protected by N-CPAP from the known deleterious effects of these drugs on the upper airways. The safety of this approach is suggested by the absence of any serious complication in the postoperative period in the last 14 patients of our series. Moreover, continuous recording of pulse oximetry in the monitored patients showed only slight falls in SaO2 (Fig  1) .
That patients with OSAS are at increased perioperative risk is suggested by isolated case reports and by biologic plausibility: prolonged apneas, favored by the use of drugs with harmful effects at the pharyngeal level and by general depressing effects on the arousability reaction, can lead to severe hypoxia, hypercapnia, acidosis, cardiac arrythmias, and death. Our first two patients may be good examples of this series of events. The respiratory arrest on the ward in patient 1, and the confusion, agitation, and hypoxemia with ventricular arrhythmia in patient 2 were most probably direct consequences of prolonged obstructive apneas. The other complications cannot be directly attributed to sleep apnea. Similarly, we cannot be sure that the dramatic change seen in the evolution of patient 2 with the institution of N-CPAP should be exclusively ascribed to his underlying OSAS being treated. Nevertheless, we believe that the history of these two patients, in conjunction with the absence of serious complications in the 14 following patients, constitutes a convincing array of evidence (albeit indirect), pointing to untreated OSAS as responsible for life-threatening postoperative complications, and to N-CPAP treatment as preventing those complications.
Surprisingly few studies report on the fate of patients with OSAS submitted to surgery. Adult OSAS is not even mentioned in recent major textbooks of anesthesia.21 '22 The articles published concern essentially surgery aimed at treating OSAS. (Fig 1) .
The vast majority of patients with sleep apnea submitted to surgery probably do not have their OSAS diagnosed, since the awareness of the existence of obstructive sleep apnea is still low among physicians.28 A recent study on unexpected postoperative deaths found that most of these occurred at night. The authors suggested that unsuspected obstructive sleep apnea could be a major contributing factor.29 A similar reasoning had been put forward previously concerning perioperative deaths in patients with autonomic neuropathies and apneas.30 To come back to our series, it is conceivable that many more than the 16 patients herein described were submitted to surgery in a 4-year period in our 900-bed university hospital and resulted in an unknown proportion of complicated outcomes or deaths. It should be noticed that our 16 patients were already followed-up at our institution for OSAS or were suspected of having OSAS during the preoperative evaluation by a few physicians with a strong interest in this disease. Our results should hence be interpreted as arising from a selected population and might not necessarily apply to the unselected patient with OSAS facing a surgical procedure. Nevertheless, the recent flourish of case reports describing severe perioperative complications in untreated patients with OSAS or with an a posteriori suspected OSAS suggests that our data could be extended to many such patients. 2031 '32 Only a prospective large-scale study will allow us to better define the population at risk and to assess the exact extent of the risk. Until then, our series suggests that obstructive sleep apnea carries an increased perioperative risk, and that treatment with N-CPAP seems to remove this increased risk. Indeed, not only did our treated patients experience no major complication, but they left the ICU and the hospital according to the normal time schedule for our institution and for their type of surgery.
The economic implications of our conclusions merit consideration. If OSAS is suspected in someone awaiting a surgical procedure, extra cost will arise from one to two PSGs (a diagnostic one and one under nCPAP, or a split-night one), and from two to four in-hospital nights habituation to N-CPAP as it is our policy. This cost should be compared with the one arising from potential complications and prolonged ICU and hospital stay. In conclusion, our observations suggest that patients with OSAS started on a regimen of N-CPAP before surgery and put on a regimen of N-CPAP as soon as extubated can be treated safely for any type of surgery with conventional anesthetic and analgesic techniques, and they are likely to follow perioperative courses comparable to those of patients without OSAS.
